期刊文献+

P-LCR在非酒精性脂肪肝中的诊断价值 被引量:1

Diagnostic value of P-LCR in non-alcoholic fatty liver
在线阅读 下载PDF
导出
摘要 目的探讨非酒精性脂肪肝(NAFLD)患者大血小板比率(P-LCR)的临床意义。方法应用Sysmex XE-2100测定56例NAFLD患者和50例健康者(对照组)的P-LCR。结果 NAFLD组P-LCR与健康组比较显著升高(P<0.05),P-LCR与MPV及PDW呈正相关,相关系数分别为0.728(P=0.000)和0.772(P=0.000)。结论 NAFLD患者血小板参数中,以P-LCR升高最为明显,其他依次为PDW、MPV,P-LCR的检测对于NAFLD的诊断具有重要的临床意义。 Objective To evaluate the clinical significance of platelet ratio (P-LCR) in patients with non-alcoholic fatty liver (NAFLD). Methods P-LCR was detected in 56 cases of NAFLD and 60 healthy persons by Sysmex XE- 2100 determination technique. Results The P-LCR level in patients with NAFLD was obviously higher than that in healthy persons. P-LCR level was significantly correlated with MPV and PDW in NAFLD patients, and the correlation co- efficients were respectively 0. 728 (P = 0. 000) and 0. 772 (P = 0. 000). Conclusion The P-LCR is the most impor- tant index in platelet parameters in patients with NAFLD, followed by PDW and MPV. P-LCR can serve as an sensitive indicator for diagnosis of NAFLD.
出处 《胃肠病学和肝病学杂志》 CAS 2013年第3期219-220,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 非酒精性脂肪肝 大血小板比率 平均血小板体积 血小板分布宽度 Non-alcoholic fatty liver P-LCR MPV PDW
  • 相关文献

参考文献2

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1517
  • 2Clouston AD,Powell EE. Nonalcoholic fatyy liver diseasa:is all the fat bad?[J].Intern Med J,2004,34(4): 181-197.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1516

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部